Rakesh Subramanian net worth and biography

Rakesh Subramanian Biography and Net Worth

Rocky Subramanian is Chief Revenue Officer at Ceridian. Rocky is responsible for all sales activities globally, including developing and leading go-to-market strategies, advisory services, and sales operations for Ceridian’s complete portfolio of products.

Prior to joining Ceridian in 2020, Rocky was a member of SAP’s senior leadership team as the Managing Director for the U.S. Midwest region.

Passionate about entrepreneurship, he advises early-stage start-ups as a volunteer mentor and supports organizations with missions focused on education accessibility and eradicating hunger.

Rocky holds a bachelor’s degree in physics and computer science from Augustana College in Rock Island, Illinois.

What is Rakesh Subramanian's net worth?: The estimated net worth of Rakesh Subramanian is at least $3.54 million as of February 27th, 2023. Mr. Subramanian owns 59,444 shares of Ceridian HCM stock worth more than $3,541,674 as of April 26th. This net worth estimate does not reflect any other investments that Mr. Subramanian may own. Learn More about Rakesh Subramanian's net worth.
How do I contact Rakesh Subramanian?: The corporate mailing address for Mr. Subramanian and other Ceridian HCM executives is 3311 EAST OLD SHAKOPEE ROAD, MINNEAPOLIS MN, 55425. Ceridian HCM can also be reached via phone at (952) 853-8100 and via email at [email protected]. Learn More on Rakesh Subramanian's contact information.
Has Rakesh Subramanian been buying or selling shares of Ceridian HCM?: Rakesh Subramanian has not been actively trading shares of Ceridian HCM in the last ninety days. Most recently, Rakesh Subramanian sold 3,692 shares of the business's stock in a transaction on Monday, February 27th. The shares were sold at an average price of $72.44, for a transaction totalling $267,448.48. Following the completion of the sale, the executive vice president now directly owns 59,444 shares of the company's stock, valued at $4,306,123.36. Learn More on Rakesh Subramanian's trading history.
Who are Ceridian HCM's active insiders?: Ceridian HCM's insider roster includes Christopher Armstrong (COO), Arthur Gitajn (CFO), Thomas Hagerty (Director), Noémie Heuland (CFO), Stephen Holdridge (Insider), Jeffrey Jacobs (Insider), Joseph Korngiebel (EVP), William McDonald (EVP), David Ossip (CEO), Rakesh Subramanian (EVP), Gerald Throop (Director), and Leagh Turner (COO). Learn More on Ceridian HCM's active insiders.
Are insiders buying or selling shares of Ceridian HCM?: During the last twelve months, insiders at the sold shares 19 times. They sold a total of 76,597 shares worth more than $5,204,856.63. The most recent insider tranaction occured on November, 10th when CFO Noemie Clemence Heuland sold 3,000 shares worth more than $195,540.00. Insiders at Ceridian HCM own 4.5% of the company. Learn More about insider trades at Ceridian HCM.
Information on this page was last updated on 11/10/2023.

Rakesh Subramanian Insider Trading History at Ceridian HCM

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
2/27/2023	Sell	3,692	$72.44	$267,448.48	59,444
5/9/2022	Sell	4,315	$53.00	$228,695.00	59,441

Rakesh Subramanian Buying and Selling Activity at Ceridian HCM

Ceridian HCM Company Overview

Ceridian HCM Holding Inc., together with its subsidiaries, operates as a human capital management (HCM) software company in the United States, Canada, and internationally. It offers Dayforce, a cloud HCM platform that provides human resources, payroll, benefits, workforce management, and talent management functionality; and Powerpay, a cloud HR and payroll solution for the small business market. The company also provides Bureau solutions for payroll and payroll-related services. It sells its solutions through direct sales force and third-party channels. The company was incorporated in 2013 and is headquartered in Minneapolis, Minnesota.

Today's Range

Now: $59.58

$58.49

$60.28

50 Day Range

MA: $66.08

$58.60

$73.69

2 Week Range

Now: $59.58

$55.62

$79.66

Volume

1,197,945 shs

Average Volume

1,312,424 shs

Market Capitalization

$9.30 billion

P/E Ratio

1,986.66

Dividend Yield

N/A

Beta

1.38

Better than Bitcoin? The Biotech Stock with 46,751% Potential

From Behind the Markets | Ad

4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.

Get the name of the stock here >>>